Edison Investment Research Limited Creo Medical (CREO): Progressing on all fronts 23-Jan-2023 / 11:47 GMT/BST London, UK, 23 January 2023 Creo Medical (CREO): Progressing on all fronts 2022 was an eventful year for Creo Medical, as it progressed on all fronts of its ‘Build, Buy and Partner’ strategy. The period was marked by the increasing traction of Speedboat Inject (its flagship electrosurgical device) and its proprietary CROMA technology platform. Enhanced levels of user, robotics deals...